Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M J Cameron

Showing results (21-30 of 41) with videos related to

Pageof 5
Sort By:
The Journal of Clinical Endocrinology and Metabolism|June 1, 1986
The stimulation of prostaglandin production by two antiprogesterone steroids in human endometrial cellsR W Kelly, D L Healy, M J Cameron, et al.
Cytopathology : Official Journal of the British Society for Clinical Cytology|January 8, 2011
NUT midline carcinoma: a neoplasm with diagnostic challenges in cytologyB Zhu, W Laskin, Y Chen, et al.
Cancer Gene Therapy|January 1, 1996
Therapeutic efficacy of T cells derived from lymph nodes draining a poorly immunogenic tumor transduced to secrete granulocyte-macrophage colony-stimulating factorM J Arca, J C Krauss, A Aruga, et al.
Archives of Otolaryngology--Head & Neck Surgery|December 1, 1993
Immunobiologic effects of cytokine gene transfer of the B16-BL6 melanomaS E Strome, J C Krauss, M J Cameron, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 14, 1999
p38 mitogen-activated protein kinase mediates signal integration of TCR/CD28 costimulation in primary murine T cellsJ Zhang, K V Salojin, J X Gao, et al.
Journal of Immunotherapy with Emphasis on Tumor Immunology : Official Journal of the Society for Biological Therapy|November 1, 1995
A phase II trial of interleukin-2 and interferon-alpha in the treatment of metastatic colorectal carcinomaA E Chang, M J Cameron, V K Sondak, et al.
Human Gene Therapy|August 24, 2000
Biolistic-mediated interleukin 4 gene transfer prevents the onset of type 1 diabetesM J Cameron, C A Strathdee, K D Holmes, et al.
Immunology|December 14, 1999
CD40-deficient dendritic cells producing interleukin-10, but not interleukin-12, induce T-cell hyporesponsiveness in vitro and prevent acute allograft rejectionJ X Gao, J Madrenas, W Zeng, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 20, 1997
IL-4 prevents insulitis and insulin-dependent diabetes mellitus in nonobese diabetic mice by potentiation of regulatory T helper-2 cell functionM J Cameron, G A Arreaza, P Zucker, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 1997
Adoptive immunotherapy with vaccine-primed lymph node cells secondarily activated with anti-CD3 and interleukin-2A E Chang, A Aruga, M J Cameron, et al.
Pageof 5

Showing results (21-30 of 41) with videos related to

Sort By:
Pageof 5
The Journal of Clinical Endocrinology and Metabolism|June 1, 1986
The stimulation of prostaglandin production by two antiprogesterone steroids in human endometrial cellsR W Kelly, D L Healy, M J Cameron, et al.
Cytopathology : Official Journal of the British Society for Clinical Cytology|January 8, 2011
NUT midline carcinoma: a neoplasm with diagnostic challenges in cytologyB Zhu, W Laskin, Y Chen, et al.
Cancer Gene Therapy|January 1, 1996
Therapeutic efficacy of T cells derived from lymph nodes draining a poorly immunogenic tumor transduced to secrete granulocyte-macrophage colony-stimulating factorM J Arca, J C Krauss, A Aruga, et al.
Archives of Otolaryngology--Head & Neck Surgery|December 1, 1993
Immunobiologic effects of cytokine gene transfer of the B16-BL6 melanomaS E Strome, J C Krauss, M J Cameron, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 14, 1999
p38 mitogen-activated protein kinase mediates signal integration of TCR/CD28 costimulation in primary murine T cellsJ Zhang, K V Salojin, J X Gao, et al.
Journal of Immunotherapy with Emphasis on Tumor Immunology : Official Journal of the Society for Biological Therapy|November 1, 1995
A phase II trial of interleukin-2 and interferon-alpha in the treatment of metastatic colorectal carcinomaA E Chang, M J Cameron, V K Sondak, et al.
Human Gene Therapy|August 24, 2000
Biolistic-mediated interleukin 4 gene transfer prevents the onset of type 1 diabetesM J Cameron, C A Strathdee, K D Holmes, et al.
Immunology|December 14, 1999
CD40-deficient dendritic cells producing interleukin-10, but not interleukin-12, induce T-cell hyporesponsiveness in vitro and prevent acute allograft rejectionJ X Gao, J Madrenas, W Zeng, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 20, 1997
IL-4 prevents insulitis and insulin-dependent diabetes mellitus in nonobese diabetic mice by potentiation of regulatory T helper-2 cell functionM J Cameron, G A Arreaza, P Zucker, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 1997
Adoptive immunotherapy with vaccine-primed lymph node cells secondarily activated with anti-CD3 and interleukin-2A E Chang, A Aruga, M J Cameron, et al.
Pageof 5